Bristol-Myers Squibb

Bristol’s Buy of Inhibitex for Hepatitis Drug Won’t Be Last
Bloomberg
Mon, 01/9/12 - 10:12 am
Bristol-Myers Squibb
M&A
Inhibitex
hepatitis C
Shares of hepatitis C drug developers rise on Bristol-Myers' $2.5B deal for Inhibitex
Yahoo/AP
Mon, 01/9/12 - 09:57 am
hepatitis C
Bristol-Myers Squibb
M&A
Inhibitex
Gilead
Pharmasset
S&P: Bristol-Myers announcement will not affect rating
Reuters
Mon, 01/9/12 - 09:53 am
Bristol-Myers Squibb
M&A
Inhibitex
Bristol-Myers to Acquire Inhibitex for $2.5 Billion
NY Times, NY
Mon, 01/9/12 - 09:15 am
Bristol-Myers Squibb
Inhibitex
M&A
The Law Office of James C. Kelly Announces Investigation of Inhibitex, Inc.
Yahoo/PR NewsWire
Sun, 01/8/12 - 12:44 pm
Inhibitex
Bristol-Myers Squibb
M&A
Bristol to buy Inhibitex for hepatitis C treatment
Reuters
Sun, 01/8/12 - 12:45 pm
INX-189
Inhibitex
hepatitis C
Bristol-Myers Squibb
M&A
Two Short-Term Risks For Johnson & Johnson
Seeking Alpha
Fri, 01/6/12 - 11:42 am
JNJ
Abbott Laboratories
Bristol-Myers Squibb
Pfizer
Novartis
4 Pharma Stocks to Buy & Hold: Najarian
CNBC
Wed, 01/4/12 - 03:13 pm
Merck
Pfizer
Bristol-Myers Squibb
Eli Lilly
6 'Coiled Spring' Biotech Stocks To Consider In 2012
Seeking Alpha
Tue, 01/3/12 - 12:48 pm
Amgen
Biogen Idec
Bristol-Myers Squibb
Celgene
Merck
Oncothyreon
Teva Pharmaceuticals
Vical
Seattle Genetics
Difficult Road Ahead For New Teva CEO
WSJ Online
Tue, 01/3/12 - 11:41 am
Jeremy Levin
Teva Pharmaceuticals
Bristol-Myers Squibb
Pharma CEOs
Why Teva Hired A Bristol-Myers Exec As Its CEO
Pharmalot
Tue, 01/3/12 - 11:14 am
Teva Pharmaceuticals
Bristol-Myers Squibb
Jeremy Levin
Departure of ’String of Pearls’ Strategist Leaves Gap at Bristol-Myers
Bloomberg
Tue, 01/3/12 - 10:15 am
Bristol-Myers Squibb
Teva Pharmaceuticals
Jeremy Levin
Bristol’s Acquisition Plans Won’t Change With Loss of Levin to Teva
Bloomberg
Mon, 01/2/12 - 01:52 pm
Bristol-Myers Squibb
Teva Pharmaceuticals
Jeremy Levin
M&A
Top Undervalued Big Pharmaceutical Group Stocks Bought And Sold By Mega Funds
Seeking Alpha
Mon, 01/2/12 - 10:58 am
Abbott Laboratories
Allergan
AstraZeneca
Bristol-Myers Squibb
JNJ
GSK
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
Bristol-Myers' Post-Patent Plan
Motley Fool
Wed, 12/28/11 - 10:23 am
patents
Bristol-Myers Squibb
Plavix
Sanofi
Yervoy
liscensing
M&A
'Double-Dip' Blow Could Strike Big Pharmas in 2012
CNBC
Tue, 12/27/11 - 01:09 pm
patents
healthcare reform
JNJ
Abbott Laboratories
Eli Lilly
Bristol-Myers Squibb
Merck
Forbes Names The Best Big Drug Company Of 2011
Forbes
Mon, 12/26/11 - 06:01 pm
Bristol-Myers Squibb
New Dividend Kings: 5 High-Yield, Large Cap Pharma Stocks For 2012
Seeking Alpha
Mon, 12/26/11 - 08:50 am
dividends
JNJ
GSK
Pfizer
Merck
Bristol-Myers Squibb
Bristol-Myers Says Liver Cancer Drug Didn’t Meet Goals in Trial
Bloomberg
Fri, 12/23/11 - 08:44 am
liver cancer
Bristol-Myers Squibb
brivanib
Nexavar
ONYX Pharmaceuticals
Bayer
3 Big Pharmas That Have Had Big Months Headed Into Year's End
Seeking Alpha
Sun, 12/18/11 - 01:29 pm
Eli Lilly
Mylan
Bristol-Myers Squibb

Pages